Genomics transformer for diagnosing Parkinson's disease

Area of Science:

• Neuroscience
• Genetics
• Computational Biology

Background:

• Parkinson's disease (PD) is a prevalent neurodegenerative disorder with complex genetic and environmental causes, lacking definitive cures.
• Early detection of PD is challenging due to its polygenic nature and the difficulty in modeling intricate single nucleotide polymorphism (SNP) interactions.
• Existing diagnostic methods, including polygenic risk scores and traditional machine learning, often fail to capture the full complexity of genotype data.

Purpose of the Study:

• To develop a novel deep learning framework for classifying Parkinson's disease patients from healthy individuals using genotype data.
• To enhance the interpretability of genotype-based PD detection models by visualizing complex SNP-SNP interactions.
• To identify novel genetic associations and biochemical pathways implicated in Parkinson's disease development.

Main Methods:

• Implementation of a transformer encoder-based deep learning model to analyze single nucleotide polymorphism (SNP) data.
• Comparison of the proposed model's performance against traditional machine learning and multilayer perceptron (MLP) baseline models.
• Utilizing learned attention scores for model interpretability and conducting pathway enrichment analysis on identified SNP associations.

Main Results:

• The transformer encoder model demonstrated superior performance in classifying Parkinson's disease patients compared to traditional machine learning and MLP models.
• The model successfully captured and visualized complex global feature interactions within the genotype data.
• Pathway enrichment analysis corroborated the biological relevance of the identified SNP-SNP associations, suggesting novel insights into PD pathogenesis.

Conclusions:

• The developed transformer encoder model offers a powerful and interpretable approach for genotype-based Parkinson's disease detection.
• The model's ability to uncover and visualize SNP-SNP interactions provides valuable insights into the underlying biochemical pathways of PD.
• Further investigation of the identified novel SNP interactions is warranted in both laboratory and clinical settings for potential diagnostic and therapeutic advancements.